MDT · Medtronic PLC
Price
Snapshot
50 fields · last close| Market Cap | $119.2B |
| P/E | 22.55 |
| Float | 1.28B |
| Beta | 0.60 |
| Volatility | 15.0% |
| Exchange | NYSE |
| Sector | Health Care |
| Cap tier | Large cap |
| Macro sensitivity | Moderate |
| Clavix score | 80 |
| Price | 94.46 |
| Change | +1.46% |
| Prev Close | 93.10 |
| Open | 93.04 |
| Day Low | 90.97 |
| Day High | 93.72 |
| Avg Vol | 9 |
| Avg $ Vol | $815.3M |
| 52W High | 106.33 |
| 52W Low | 73.31 |
| 52W Pos | 64.1% |
| From High | −11.16% |
| From Low | +28.85% |
| Max DD 1Y | −30.00% |
| Spread | 0.10% |
| Liquidity | Deep |
| SMA 20 | +3.37% |
| SMA 50 | +9.25% |
| SMA 200 | +5.27% |
| RSI (14) | 61.7 |
| Vol 30D | 22.0% |
| Vol 90D | 29.2% |
| 1Y Range | 73–106 |
| Daily bars | 506 |
| Perf Week | +3.48% |
| Perf Month | +8.27% |
| Perf Quarter | +13.63% |
| Perf Half Y | +0.10% |
| Perf Year | +0.92% |
| Perf YTD | −1.66% |
| Prev Day | +1.46% |
| Clavix | A- |
| Debt / Eq | 0.57 |
| Curr Ratio | 2.13 |
| Int Cover | 7.8× |
| FCF Margin | 15.2% |
| Rev Growth | +9.9% |
| Profit | Profitable |
| Leverage | Low |
| Sector rank | 13 / 47 |
What MDT does
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally.
It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio.
The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.
It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, left atrial appendage exclusion systems, extracorporeal membrane oxygenation (ECMO) systems and percutaneous coronary intervention products, percutaneous angioplasty balloons, and endovenous products.
The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name.
This segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments.
The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products, as well as insulin pumps and consumables, continuous glucose monitoring systems, and sensors.
Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.
Clavix risk grade
regraded every trading dayMDT grades A-, 80 of 100. Steadiest on Macro Resilience (69), most exposed on News Sentiment (56, mixed). 2 of the 4 weighted dimensions sit above the Health Care median. Ranks 13 of 47 in Health Care by Clavix score.
How rough the ride is
| MDT | Health Care median | |
|---|---|---|
| Betavs the overall market · lower is steadier | 0.60 | 0.81 |
| Volatilityannualized | 15.0% | 20.4% |
| Max drawdown, past yearworst peak-to-trough fall | −30.0% | — |
| Typical daily movemedian absolute daily change | 0.80% | — |
| Days beyond ±3%of the last 252 sessions | 146% | — |
How its days are spread
Daily returns over the last 252 sessions in 1% bins. Moves beyond ±6% land in the end bins.
52-week range
The bar runs from the lowest to the highest close of the last 252 sessions; the marker is the latest close.
Drawdown from the 1-year peak
Percent below the running high over the last 12 months. Zero is a fresh high.
Market sensitivity
| MDT | Health Care median | |
|---|---|---|
| Beta to the markethow much it swings with the S&P 500 · lower is safer | 0.60 | 0.81 |
| Macro sensitivityrate, dollar and credit exposure bucket | Moderate | Moderate55% of 47 |
Where it sits on the macro scale
Low means rates, the dollar and credit spreads barely move it. Very High means they drive a large share of its swings. The counts are how many Health Care names sit in each bucket.
Where it ranks in its sector
Rank by Clavix score within the sector. Right is the top of the sector.
Price performance
| MDT | |
|---|---|
| 1 week | +3.5% |
| 1 month | +8.3% |
| Year to date | −1.7% |
| 1 year | +0.9% |
Context for the rank, not itself a risk measure.
Recent coverage, scored
| MDT | |
|---|---|
| Articles scoredthe most recent scored coverage, up to 30 | 30since 4 Aug |
| Average score0 most bearish, 100 most bullish | 55 |
| Bullish · bearisharticles above 60 · below 40 | 16 · 9 |
| Directionarticles whose tone is improving vs worsening | 16 ↑ 9 ↓ |
Where the article scores land
Each bar is a 10-point band of article scores. Below 40 reads bearish, above 60 bullish.
Balance sheet, against the sector
The shaded band is the middle half of the 47 Health Care names Clavix covers; the tick is the sector median.
Growth
| MDT | |
|---|---|
| Revenue growthyear over year | +9.9% |
Financial Health is shown but does not count toward the grade. Why
0–100, higher is safer. The tick on each bar is the Health Care median. Click a dimension for the evidence behind it. Financial Health is shown but does not count toward the grade.
Against Health Care
47 companies| Metric | MDT | Sector spread | Median |
|---|---|---|---|
| Beta | 0.60 | 0.81 | |
| Volatility | 15.0% | 20.4% | |
| P/E | 22.55 | 26.14 | |
| Debt / equity | 0.57 | 0.71 | |
| Current ratio | 2.13 | 1.58 | |
| FCF margin | 15.2% | 8.6% | |
| Interest coverage | 7.8× | 6.3× |
Recent news
most recent scored articles · the chip is the article’s score · click to openAn opinion piece argues Medtronic is a good buy heading into late 2026, citing value, growth, guidance, partnerships, and dividends as factors it says will drive outperformance and capital returns. The article reports no new company developments.
Medtronic reported Q1 results that beat analyst estimates on both profit and revenue, driven by broad-based growth across its businesses, and the company raised its guidance for fiscal year 2027.
Medtronic reported first-quarter earnings of $1.45 per share, beating the analyst consensus estimate of $1.39 per share. Earnings were up from $1.26 per share in the same quarter a year ago, and the headline indicates revenues beat estimates as well.
Medtronic raised the lower end of its fiscal 2027 profit forecast and revenue growth outlook, citing strong demand for its heart devices used in complex cardiovascular procedures.
The article is a short opinion piece asking whether Medtronic stock is worth holding, noting cardiovascular gains and renal denervation growth as positives but tariffs and currency headwinds as concerns. The body is too brief to contain specific numbers, events, or concrete developments.
Nearest peers by size
Health Care| Ticker | Company | Grade | Mkt cap | P/E | Beta | |
|---|---|---|---|---|---|---|
| SYK | Stryker Corp | B | $118.1B | 31.81 | 0.79 | Compare |
| CVS | CVS Health Corp | A- | $124.3B | 25.30 | 0.57 | Compare |
| ISRG | Intuitive Surgical Inc | B- | $130.7B | 41.86 | 1.48 | Compare |
| MCK | McKesson Corp | B+ | $107.4B | 23.40 | 0.30 | Compare |
| ELV | Elevance Health Inc | B+ | $89.95B | 17.69 | 0.65 | Compare |
| HCA | HCA Healthcare Inc | B+ | $88.59B | 13.06 | 1.14 | Compare |
| CI | Cigna Group | B+ | $75.64B | 11.64 | 0.27 | Compare |
| ABT | Abbott Laboratories | B+ | $188.2B | 34.68 | 0.54 | Compare |
You just read one holding. Clavix reads the whole portfolio.
Every position you own, graded on the same five dimensions, with an alert when a grade moves. Three months free on iPhone.